Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Head and Neck Neoplasms × liposomal doxorubicin × Clear all

Sponsor

Conditions

Ovarian Neoplasms 27 Breast Neoplasms 19 Fallopian Tube Neoplasms 18 Multiple Myeloma 14 Carcinoma, Ovarian Epithelial 12 Lymphoma 7 Triple Negative Breast Neoplasms 4 Neoplasms, Plasma Cell 3 Prostatic Neoplasms 2 Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Large B-Cell, Diffuse 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Subcutaneous panniculitis-like T-cell lymphoma 1 Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma, Kaposi 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Peritoneal Neoplasms 1 Patient Participation 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neurofibrosarcoma 1 Neuroendocrine Tumors 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1

Interventions

Cisplatin 60 Cetuximab 51 Radiotherapy 34 pembrolizumab 26 Radiotherapy, Intensity-Modulated 23 Carboplatin 21 Docetaxel 19 Paclitaxel 18 Fluorouracil 17 Pemetrexed 9 Erlotinib Hydrochloride 9 Nivolumab 8 Gemcitabine 8 Radiation 7 Drug Therapy 7 Bevacizumab 7 durvalumab 6 Panitumumab 6 Everolimus 6 epacadostat 5 Surgical Procedures, Operative 5 Standard of Care 5 Lapatinib 5 Gefitinib 5 Albumin-Bound Paclitaxel 5 130-nm albumin-bound paclitaxel 5 Oxaliplatin 4 Ipilimumab 4 Cyclophosphamide 4 Celecoxib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡